| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2011 | US20110183937 Agent for Combating Ectoparasites |
| 07/28/2011 | US20110183936 Regimens for intra-articular viscosupplementation |
| 07/28/2011 | US20110183935 Heartwater |
| 07/28/2011 | US20110183934 Methods and compositions to improve germ cell and embryo survival and function |
| 07/28/2011 | US20110183933 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors |
| 07/28/2011 | US20110183932 Three-component bone cement |
| 07/28/2011 | US20110183931 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 07/28/2011 | US20110183930 Water soluble and activable phenolics derivatives with dermocosmetic and therapeutic applications and process for preparing said derivatives |
| 07/28/2011 | US20110183929 Standardized extract and fraction from hancornia speciosa leaves and pharmaceutical composition thereof |
| 07/28/2011 | US20110183928 3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof |
| 07/28/2011 | US20110183927 Compositions Comprising Sugar-Cysteine Products |
| 07/28/2011 | US20110183926 Treatment using continuous low dose application of sugar analogs |
| 07/28/2011 | US20110183915 Small Molecule Cancer Treatments that cause Necrosis in Cancer Cells but do not Affect Normal Cells |
| 07/28/2011 | US20110183912 Agent for promoting neuronal differentiation and method therefor |
| 07/28/2011 | US20110183910 Biglycan and related therapeutics and methods of use |
| 07/28/2011 | US20110183907 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 07/28/2011 | US20110183905 Pharmaceutical compositions |
| 07/28/2011 | US20110183904 Methods and compositions for altering behavior associated with autism spectrum disorder |
| 07/28/2011 | US20110183899 Methods and compositions for the treatment of obesity |
| 07/28/2011 | US20110183898 Compositions for delivering peptide yy and pyy ag0nists |
| 07/28/2011 | US20110183897 Variant activin receptor polypeptides |
| 07/28/2011 | US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors |
| 07/28/2011 | US20110183894 Antiviral activity of the protein scytovirin and methods of use |
| 07/28/2011 | US20110183892 Methods for the treatment of viral conditions |
| 07/28/2011 | US20110183890 Methods for modulating angiogenesis via dystrophin dp71 |
| 07/28/2011 | US20110183366 Methods for achieving a protective ACE2 expression level to treat kidney disease and hypertension |
| 07/28/2011 | US20110183034 Enhancement of magenesium uptake in mammals |
| 07/28/2011 | US20110183021 Compositions Containing Purine Nucleosides and Manganese and Their Uses |
| 07/28/2011 | US20110183019 Methods of screening for and treating autism spectrum disorders and compositions for same |
| 07/28/2011 | US20110183018 Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function |
| 07/28/2011 | US20110183016 Film-forming liquid formulations for drug release to hair and scalp |
| 07/28/2011 | US20110183011 Composition and method for topical treatment of skin lesions |
| 07/28/2011 | US20110183009 Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity |
| 07/28/2011 | US20110183006 Compositions and methods for treating osteoarthritis |
| 07/28/2011 | US20110182997 Suspension formulations |
| 07/28/2011 | US20110182996 Surface modified nanoparticles, methods of their preparation, and uses thereof for gene and drug delivery |
| 07/28/2011 | US20110182994 Methods and systems for production of nanoparticles |
| 07/28/2011 | US20110182988 Gastroretentive pharmaceutical dosage form |
| 07/28/2011 | US20110182987 Pharmaceutical dosage form for the site-specific delivery of more than one active pharmaceutical ingredient |
| 07/28/2011 | US20110182986 Controlled release composition |
| 07/28/2011 | US20110182985 Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof |
| 07/28/2011 | US20110182984 High Content Sodium Ibuprofen Granules, Their Preparation And Their Use In Preparing Non-Effervescent Solid Dosage Forms |
| 07/28/2011 | US20110182982 Liposome treatment of viral infections |
| 07/28/2011 | US20110182980 Composition for suppressing expression of target gene |
| 07/28/2011 | US20110182979 In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation |
| 07/28/2011 | US20110182978 Activated nitric oxide donors and methods of making and using thereof |
| 07/28/2011 | US20110182977 Topical composition containing ibuprofen |
| 07/28/2011 | US20110182973 Polymerase inhibitors and the use thereof for the treatment of tumors |
| 07/28/2011 | US20110182972 Low-concentration capsaicin patch and methods for treating neuropathic pain |
| 07/28/2011 | US20110182971 Transepidermal drug delivery system containing tulobuterol |
| 07/28/2011 | US20110182968 Interpenetrating polymer network hydrogel corneal prosthesis |
| 07/28/2011 | US20110182967 Implants for administering substances and methods of producing implants |
| 07/28/2011 | US20110182966 Intracameral sustained release therapeutic agent implants |
| 07/28/2011 | US20110182964 Vascular Stent Which Elutes Amino Acid-Methyl-Ester Derivatives for the Treatment of Vulnerable Plaque and Vascular Disease |
| 07/28/2011 | US20110182963 Osteoimplant and methods for making |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | US20110182953 Polymorphic form of calcium acamprosate |
| 07/28/2011 | US20110182952 Drug delivery from embolic agents |
| 07/28/2011 | US20110182947 Hydrogel-driven drug dosage form |
| 07/28/2011 | US20110182946 Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques |
| 07/28/2011 | US20110182943 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 07/28/2011 | US20110182938 Influenza nucleic acid molecules and vaccines made therefrom |
| 07/28/2011 | US20110182927 Inhibitors of DNA Immunostimulatory Sequence Activity |
| 07/28/2011 | US20110182917 Therapeutic or prophylactic agent for generalized pain syndrome |
| 07/28/2011 | US20110182914 Methods and compositions |
| 07/28/2011 | US20110182912 Agents and methods for denervation |
| 07/28/2011 | US20110182909 Glufosfamide combination therapy |
| 07/28/2011 | US20110182902 Recombination Sequence (RS) Rearrangement Frequency as a Measure of Central B Cell Tolerance |
| 07/28/2011 | US20110182901 Full length large t tumor antigen of merkel cell polyomavirus as a therapeutic target in merkel cell carcinoma |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | US20110182888 Administration of an Inhibitor of HDAC, an Inhibitor of HER-2, and a Selective Estrogen Receptor Modulator |
| 07/28/2011 | US20110182886 Compositions and methods for inhibiting tumor progression |
| 07/28/2011 | US20110182882 Icotinib Hydrochloride, Synthesis, Crystalline Forms, Pharmaceutical Compositions, and Uses Thereof |
| 07/28/2011 | US20110182880 Combination Therapies Against Cancer |
| 07/28/2011 | US20110182869 Treatment of gut motility disorders |
| 07/28/2011 | US20110182867 Modulation of bcl11a for treatment of hemoglobinopathies |
| 07/28/2011 | US20110182865 Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections |
| 07/28/2011 | US20110182864 Compositions containing inclusion complexes |
| 07/28/2011 | US20110182858 Silibinin component for the treatment of hepatitis |
| 07/28/2011 | US20110182857 Delivery of Drugs to Mucosal Surfaces |
| 07/28/2011 | US20110182856 Inhibitors of serine proteases |
| 07/28/2011 | US20110182854 Hcv protease inhibitors |
| 07/28/2011 | US20110182850 Organic compounds and their uses |
| 07/28/2011 | US20110182849 Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
| 07/28/2011 | US20110182832 Perfume compositions |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | US20110182822 Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof |
| 07/28/2011 | US20110182819 Methods and Compounds for Promoting Vessel Regression |
| 07/28/2011 | DE102010005953A1 Verfahren zur Herstellung von Nebivolol Process for the preparation of nebivolol |
| 07/28/2011 | DE102010001179A1 Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen Guluronsäure- use of hydrogels based and / or mannuronsäurehaltiger polysaccharides for treatment of damage to the nervous system, for the promotion of nerve growth, for the treatment of neurodegenerative diseases and for the cultivation of neurons |
| 07/28/2011 | CA2792993A1 Special composition for the use thereof as a drug |
| 07/28/2011 | CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| 07/28/2011 | CA2787900A1 Quantitative analysis of vitamin d3, vitamin d2, and metabolites thereof |
| 07/28/2011 | CA2787782A1 Therapeutic substituted chlorocyclopentanols |
| 07/28/2011 | CA2787756A1 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 07/28/2011 | CA2787722A1 A new series of artemisinin derivatives and process for preparation thereof |
| 07/28/2011 | CA2787714A1 Inhibitors of pi3 kinase |
| 07/28/2011 | CA2787684A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases |
| 07/28/2011 | CA2787573A1 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
| 07/28/2011 | CA2787514A1 Intracameral sustained release therapeutic agent implants |